First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report) saw strong trading volume on Monday . 108,792 shares were traded during trading, an increase of 309% from the previous session’s volume of 26,627 shares.The stock last traded at $160.69 and had previously closed at $160.20.
First Trust NYSE Arca Biotechnology Index Fund Stock Up 0.9 %
The stock’s 50 day moving average price is $153.74 and its two-hundred day moving average price is $151.77. The stock has a market cap of $1.22 billion, a price-to-earnings ratio of 17.20 and a beta of 0.86.
Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Independence Bank of Kentucky purchased a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund in the first quarter valued at approximately $31,000. Principal Securities Inc. purchased a new stake in First Trust NYSE Arca Biotechnology Index Fund in the 4th quarter worth $32,000. Zurcher Kantonalbank Zurich Cantonalbank raised its position in First Trust NYSE Arca Biotechnology Index Fund by 14.5% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 932 shares of the company’s stock worth $148,000 after acquiring an additional 118 shares during the period. Main Street Financial Solutions LLC purchased a new position in First Trust NYSE Arca Biotechnology Index Fund in the 4th quarter valued at about $201,000. Finally, Jones Financial Companies Lllp acquired a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund in the fourth quarter worth approximately $201,000.
About First Trust NYSE Arca Biotechnology Index Fund
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
See Also
- Five stocks we like better than First Trust NYSE Arca Biotechnology Index Fund
- Dividend Capture Strategy: What You Need to Know
- Intuitive Surgical Stock Outperforms Market: Highs on the Horizon
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Has This Leading Tech Stock Halted the AI Surge?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Revolutionary Battery Stock Gains Momentum with 3D Silicon-Anodes
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.
